‌

US Patent 11337976 Compounds and methods for kinase modulation, and indications therefor

Patent 11337976 was granted and assigned to Plexxikon Inc. on May, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Ying Zhang0

Chao Zhang0

Guoxian Wu0

Hanna Cho0

Jack Lin0

Jiazhong Zhang0

Marika Nespi0

Prabha N. Ibrahim0

...

Date of Patent

May 24, 2022

0

Patent Application Number

154355690

Date Filed

February 17, 2017

0

Patent Citations

US Patent 10227357 Compounds and methods for kinase modulation, and indications therefor

US Patent 10301280 Compounds and methods for kinase modulation, and indications therefor

US Patent 10316032 Solid forms of a compound for modulating kinases

US Patent 10370374 Heterocyclic compounds and uses thereof

US Patent 10399975 Synthesis of a compound that modulates kinases

US Patent 10421761 Compounds for kinase modulation, and indications therefor

US Patent 10426760 Compounds and methods for kinase modulation, and indications therefor

US Patent 10428067 Compounds and methods for kinase modulation

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Compounds active on protein kinases are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11337976 Compounds and methods for kinase modulation, and indications therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.